Cigna Foundation Launches Veteran Mental Health Grant Program
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Source: Newsfilter
- Funding Amount and Goals: The Cigna Foundation offers $150,000 annual grants for veteran mental health initiatives, aiming to enhance mental well-being through housing stability and coordinated resources, reflecting a strong commitment to veteran welfare.
- Application Criteria and Deadline: The grant program is open to nonprofits serving veterans in ten priority states, including Arizona and Florida, with applications due by July 9 at 5 PM ET, ensuring timely support for veterans in need.
- Long-term Commitment and Impact: Cigna Foundation has pledged $9 million over three years to improve housing stability and related support services for approximately 40,000 homeless veterans, significantly enhancing their quality of life.
- Community Collaboration and Success Stories: By partnering with local organizations, the Cigna Foundation has invested over $6 million in 46 nonprofit partners, providing personalized services that help veterans achieve stable living paths, demonstrating the effectiveness of community-based solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CI
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 280.680
Low
300.00
Averages
335.63
High
378.00
Current: 280.680
Low
300.00
Averages
335.63
High
378.00
About CI
The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
US Stocks Close Mixed: Dow Hits All-Time High
- Dow Hits Record High: The Dow Jones Industrial Average rose 1.73% to reach an all-time high, reflecting strong rebounds in bank and managed healthcare stocks, despite a 0.53% decline in the Nasdaq 100 due to weakness in technology stocks.
- Crude Oil Prices Decline: WTI crude oil prices fell over 3%, lowering inflation expectations and pushing the 10-year T-note yield down 2 basis points to 4.47%, providing support for both stock and bond markets, indicating a complex market reaction to economic outlooks.
- Jobless Claims Rise: Initial jobless claims in the US increased by 13,000 to 225,000, marking a 3.75-month high, suggesting a weaker labor market, although unit labor costs were unexpectedly revised down to 1.8%, easing concerns over wage pressures.
- Earnings Season Summary: As of Thursday, 83% of the 494 S&P 500 companies reported earnings that beat estimates, with Q1 earnings projected to rise 12% year-over-year, but excluding the tech sector, growth is only about 3%, the lowest in two years, reflecting divergence across industries.
See More
Dow Jones Hits All-Time High Amid Mixed Market Performance
- Dow Jones High: The Dow Jones Industrial Average surged 1.49% to reach a new all-time high, demonstrating market resilience driven by strong performance in managed healthcare stocks, despite overall market pressures.
- Tech Sector Decline: Broadcom's stock plummeted over 14% due to disappointing AI revenue forecasts, leading to a broader decline in chipmakers, while CrowdStrike fell more than 8% despite beating Q1 earnings expectations, reflecting market caution towards tech stocks.
- Mixed Economic Data: Initial jobless claims rose to 225,000, a 3.75-month high, indicating a weaker labor market, while Q1 nonfarm productivity was revised down to 0.3%, below expectations, potentially impacting future economic growth outlooks.
- Oil Price Impact: WTI crude oil prices fell over 3% amid a ceasefire agreement between Israel and Lebanon, which lowered inflation expectations and provided support for both stock and bond markets, improving investor sentiment.
See More
Mixed US Stock Market with Tech Stocks Under Pressure
- Tech Stock Decline: Broadcom (AVGO) shares plummeted over 15% after its AI revenue forecast fell short, marking it as the largest decliner in the Nasdaq 100, which reflects growing concerns about the tech sector and may dampen investor confidence.
- Weak Employment Data: Initial jobless claims in the US rose by 13,000 to 225,000, reaching a 3.75-month high, indicating a weakening labor market that could lead to downward revisions in growth expectations.
- Healthcare Stocks Strong: UnitedHealth Group (UNH) surged over 6%, leading gains in the S&P 500, after Bank of America upgraded its rating from neutral to buy with a price target of $450, showcasing resilience in the healthcare sector.
- International Market Volatility: European markets showed mixed results, with Eurozone April retail sales falling 0.4% month-over-month, worse than the expected 0.3%, indicating weak consumer spending that could pressure future economic growth.
See More
Cigna Stops Coverage for GLP-1 Weight Loss Drugs
- Policy Change: Cigna announced that effective July 1, it will cease coverage for GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, impacting nearly 67,700 employees, indicating a strategic shift in cost management.
- Employee Impact: A spokesperson confirmed that current users of GLP-1 weight-loss drugs can obtain medications through manufacturers' direct-to-consumer sites or TrumpRx using cash-pay options, but these purchases will not count towards deductibles, potentially increasing financial burdens on employees.
- Coverage Limitations: This policy change only affects Cigna's employee health plan and will not impact other plans or coverage for GLP-1 drugs targeting type 2 diabetes, highlighting the company's strategic distinction between weight-loss and diabetes medications.
- Transition Arrangements: Cigna stated that existing prescriptions for GLP-1 drugs can be refilled until June 30, and employees with insurance approvals will continue to receive coverage for older generic anti-obesity medications, demonstrating the company's commitment to supporting employees during the transition.
See More
Cigna Stops Coverage for GLP-1 Weight Loss Drugs
- Policy Change Announcement: Cigna has decided to stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, effective July 1, reflecting the company's response to increased availability of these medications.
- Employee Communication: The change was communicated to employees via email on June 1, demonstrating Cigna's efforts in transparency and communication, although this move may raise concerns among employees regarding health management resources.
- Commitment to Health Management: A Cigna spokesperson confirmed that despite ending coverage for GLP-1 drugs, the company remains committed to supporting employee health through a variety of weight management programs and resources, aiming to mitigate potential negative impacts from the policy change.
- Market Impact Potential: This policy shift may affect the market demand for GLP-1 drugs, particularly within Cigna's employee base, potentially prompting other insurers to reassess their coverage, thereby influencing dynamics across the industry.
See More
Cigna Foundation Launches Veteran Mental Health Grant Program
- Funding Amount and Goals: The Cigna Foundation offers $150,000 annual grants for veteran mental health initiatives, aiming to enhance mental well-being through housing stability and coordinated resources, reflecting a strong commitment to veteran welfare.
- Application Criteria and Deadline: The grant program is open to nonprofits serving veterans in ten priority states, including Arizona and Florida, with applications due by July 9 at 5 PM ET, ensuring timely support for veterans in need.
- Long-term Commitment and Impact: Cigna Foundation has pledged $9 million over three years to improve housing stability and related support services for approximately 40,000 homeless veterans, significantly enhancing their quality of life.
- Community Collaboration and Success Stories: By partnering with local organizations, the Cigna Foundation has invested over $6 million in 46 nonprofit partners, providing personalized services that help veterans achieve stable living paths, demonstrating the effectiveness of community-based solutions.
See More
US Stocks Close Mixed: Dow Hits All-Time High
- Dow Hits Record High: The Dow Jones Industrial Average rose 1.73% to reach an all-time high, reflecting strong rebounds in bank and managed healthcare stocks, despite a 0.53% decline in the Nasdaq 100 due to weakness in technology stocks.
- Crude Oil Prices Decline: WTI crude oil prices fell over 3%, lowering inflation expectations and pushing the 10-year T-note yield down 2 basis points to 4.47%, providing support for both stock and bond markets, indicating a complex market reaction to economic outlooks.
- Jobless Claims Rise: Initial jobless claims in the US increased by 13,000 to 225,000, marking a 3.75-month high, suggesting a weaker labor market, although unit labor costs were unexpectedly revised down to 1.8%, easing concerns over wage pressures.
- Earnings Season Summary: As of Thursday, 83% of the 494 S&P 500 companies reported earnings that beat estimates, with Q1 earnings projected to rise 12% year-over-year, but excluding the tech sector, growth is only about 3%, the lowest in two years, reflecting divergence across industries.
See More
Dow Jones Hits All-Time High Amid Mixed Market Performance
- Dow Jones High: The Dow Jones Industrial Average surged 1.49% to reach a new all-time high, demonstrating market resilience driven by strong performance in managed healthcare stocks, despite overall market pressures.
- Tech Sector Decline: Broadcom's stock plummeted over 14% due to disappointing AI revenue forecasts, leading to a broader decline in chipmakers, while CrowdStrike fell more than 8% despite beating Q1 earnings expectations, reflecting market caution towards tech stocks.
- Mixed Economic Data: Initial jobless claims rose to 225,000, a 3.75-month high, indicating a weaker labor market, while Q1 nonfarm productivity was revised down to 0.3%, below expectations, potentially impacting future economic growth outlooks.
- Oil Price Impact: WTI crude oil prices fell over 3% amid a ceasefire agreement between Israel and Lebanon, which lowered inflation expectations and provided support for both stock and bond markets, improving investor sentiment.
See More
Mixed US Stock Market with Tech Stocks Under Pressure
- Tech Stock Decline: Broadcom (AVGO) shares plummeted over 15% after its AI revenue forecast fell short, marking it as the largest decliner in the Nasdaq 100, which reflects growing concerns about the tech sector and may dampen investor confidence.
- Weak Employment Data: Initial jobless claims in the US rose by 13,000 to 225,000, reaching a 3.75-month high, indicating a weakening labor market that could lead to downward revisions in growth expectations.
- Healthcare Stocks Strong: UnitedHealth Group (UNH) surged over 6%, leading gains in the S&P 500, after Bank of America upgraded its rating from neutral to buy with a price target of $450, showcasing resilience in the healthcare sector.
- International Market Volatility: European markets showed mixed results, with Eurozone April retail sales falling 0.4% month-over-month, worse than the expected 0.3%, indicating weak consumer spending that could pressure future economic growth.
See More
Cigna Stops Coverage for GLP-1 Weight Loss Drugs
- Policy Change: Cigna announced that effective July 1, it will cease coverage for GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, impacting nearly 67,700 employees, indicating a strategic shift in cost management.
- Employee Impact: A spokesperson confirmed that current users of GLP-1 weight-loss drugs can obtain medications through manufacturers' direct-to-consumer sites or TrumpRx using cash-pay options, but these purchases will not count towards deductibles, potentially increasing financial burdens on employees.
- Coverage Limitations: This policy change only affects Cigna's employee health plan and will not impact other plans or coverage for GLP-1 drugs targeting type 2 diabetes, highlighting the company's strategic distinction between weight-loss and diabetes medications.
- Transition Arrangements: Cigna stated that existing prescriptions for GLP-1 drugs can be refilled until June 30, and employees with insurance approvals will continue to receive coverage for older generic anti-obesity medications, demonstrating the company's commitment to supporting employees during the transition.
See More
Cigna Stops Coverage for GLP-1 Weight Loss Drugs
- Policy Change Announcement: Cigna has decided to stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, effective July 1, reflecting the company's response to increased availability of these medications.
- Employee Communication: The change was communicated to employees via email on June 1, demonstrating Cigna's efforts in transparency and communication, although this move may raise concerns among employees regarding health management resources.
- Commitment to Health Management: A Cigna spokesperson confirmed that despite ending coverage for GLP-1 drugs, the company remains committed to supporting employee health through a variety of weight management programs and resources, aiming to mitigate potential negative impacts from the policy change.
- Market Impact Potential: This policy shift may affect the market demand for GLP-1 drugs, particularly within Cigna's employee base, potentially prompting other insurers to reassess their coverage, thereby influencing dynamics across the industry.
See More
Cigna Foundation Launches Veteran Mental Health Grant Program
- Funding Amount and Goals: The Cigna Foundation offers $150,000 annual grants for veteran mental health initiatives, aiming to enhance mental well-being through housing stability and coordinated resources, reflecting a strong commitment to veteran welfare.
- Application Criteria and Deadline: The grant program is open to nonprofits serving veterans in ten priority states, including Arizona and Florida, with applications due by July 9 at 5 PM ET, ensuring timely support for veterans in need.
- Long-term Commitment and Impact: Cigna Foundation has pledged $9 million over three years to improve housing stability and related support services for approximately 40,000 homeless veterans, significantly enhancing their quality of life.
- Community Collaboration and Success Stories: By partnering with local organizations, the Cigna Foundation has invested over $6 million in 46 nonprofit partners, providing personalized services that help veterans achieve stable living paths, demonstrating the effectiveness of community-based solutions.
See More
